Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...

Alzhemier’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...

A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...

ApoE is a key genetic risk factor for certain forms of Alzheimer's disease, whose 3 variants (E2, E3, E4) influence the progression of the disease in different ways. People carrying the E4 allele have ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Delve into the challenges Black Americans face with Alzheimer’s and the urgent need for better prevention, care, and ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...